Conference Program

Conference Program

Dated 15.01.19 – Subject to Change

09:00-09:15

WELCOME REMARKS

09:00 Rafi Gidron, IBT Founder and Chairman, Israel
09:05 Miri Polachek, Founding Executive Director, Israel Brain Technologies (ex-officio) CEO, Joy Ventures
09:10 Karin Mayer Rubinstein, CEO, IATI, Israel

Pear Therapeutics is leading development of a new treatment class known as prescription digital therapeutics, or PDTs. PDTs are designed to directly treat disease, tested for safety and efficacy in randomized clinical trials, evaluated by the FDA, and prescribed by healthcare providers. Dr. McCann will discuss this new treatment class and share recent developments across the portfolio, including the commercial launch of reSET, for the treatment of Substance Use Disorder, and reSET-O, for the treatment of Opioid Use Disorder. He will also provide a view into the company's pipeline, with PDTs in development across a range of serious diseases.

Corey McCann, President and CEO of Pear Therapeutics, USA

09:45 -10:30

FIRESIDE CHAT

Moran Cerf, Professor, Neuroscience & Business, Kellogg School of Management, Northwestern University, USA

Alim Louis Benabid, Professor, Chairman of the Board, Clinatec; Member of the Academy of Sciences; Professor Emeritus of Biophysics at Joseph Fourier University; Scientific Advisor at the Atomic Energy Commission; Clinatec, Edmond J Safra Research Center, LETI-Minatec, France

Chair: Hagai Bergman, Professor of Physiology, The Hebrew University of Jerusalem; President, Israel Society for Neuroscience (ISFN), Israel

11:00 CLOSING THE LOOP ON PARKINSON'S DISEASE – FROM PHYSIOLOGY TO TREATMENT AND BACK
Hagai Bergman,
Professor of Physiology, The Hebrew University of Jerusalem; President, Israel Society for Neuroscience (ISFN) (Israel)

11:15 NEURAL CO-PROCESSING: SHIFTING OUR MINDSET FROM MODULATING TO RESTORING DISEASED BRAIN CIRCUITS
Timothy Denison,
Royal Academy of Engineering Chair in Emerging Technologies, Department of Engineering Science, Nuffield Department of Clinical Neuroscience, MRC Brain Network Dynamics Unit, Oxford University (UK)

11:30 Panel discussion
• Hagai Bergman,
Professor of Physiology, The Hebrew University of Jerusalem; President, Israel Society for Neuroscience (ISFN) (Israel)
Timothy Denison, Royal Academy of Engineering Chair in Emerging Technologies, Department of Engineering Science, Nuffield Department of Clinical Neuroscience, MRC Brain Network Dynamics Unit, Oxford University (UK)
Imad Younis, President, Alpha Omega
Ziv Peremen, VP Medical Solutions, ElMindA
Zvi Israel,Director, Center for Functional and Restorative Surgery, Dept. of Neurosurgery, Hadassah Medical Center, Jerusalem

Chair: Anya Eldan, VP of the Israel Innovation Authority & Head of Startup Division, Israel

Keynote lecture: David Ben Shimol, Product Manager at Google, Research and Machine Intelligence, Israel

Panel discussion:
• Anya Eldan, VP of the Innovation Authority and Head of Startup Division, Israel Innovation Authority, Israel
• Dan Schwarzman, CEO, MindUp, Israel
• Ittai Harel, Managing General Partner, Pitango Venture Capital, Israel
• Shlomo Mendlovic, Director, Shalvata Mental Health Center, Israel
• Eran Harary, Senior Director, Global Clinical Development., Neuropsychiatry, Teva Pharmaceuticals Industries Ltd., Israel

Startups Spotlight

• Brainmarc
• Neurolief
• Novotalk
• TrainPain

Recent theoretical work provides new insights into the computational principles that govern the dynamics of neural systems and the processing of information. This session will discuss how computational ideas can be translated into reliable neurotechnologies.

Chair: Oren Shriki, Assistant Professor, Dept. of Cognitive and Brain Sciences and Dept. of Computer Science, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Israel

CLOSING THE CHASM: ACCELERATING TRANSLATIONAL NEUROSCIENCE APPLICATIONS THROUGH AUTOMATED BIOSIGNAL ANALYSIS IN THE CLOUD
16:30 Tim Mullen,
PhD, Founder & CEO, Research Director, Intheon, USA

16:50 MEASURING PHYSIOLOGY AND BEHAVIOR IN YOUNG CHILDREN WITH AUTISM
Ilan Dinstein,
Negev Autism Center, Ben-Gurion University, Israel

17:10 TRANSLATIONAL NEUROREHABILITATION: DEFINITIONS, CHALLENGES AND OPPORTUNITIES. INTRODUCTION OF THE BGU-ALEH NEGEV INITIATIVE
Simona Bar-Haim,
Founder, Step of Mind; Head, The laboratory for Motor Control and Rehabilitation of Walking, Ben Gurion University, Israel
Lior Shmuelof, Head, Brain & Action Lab, Ben Gurion University, Israel

17:30 LIVING ON THE EDGE: ON CRITICAL BRAIN DYNAMICS AND ITS APPLICATIONS TO DIAGNOSING NEUROLOGICAL DISORDERS
Oren Shriki,
Assistant Professor, Dept. of Cognitive and Brain Sciences and Dept. of Computer Science, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Israel

17:50 Q&A

Neurowellness is an emerging field focused on emotional wellbeing and resilience. There has been an exponential growth in scientific research and technological developments dedicated to understanding and enhancing the human experience. This session will explore the science behind emotional wellbeing, showcase the latest technologies in the field and discuss how these technologies will reach the individual consumer to enhance our lives.

The field of Artificial Intelligence takes inspiration from human intelligence and from the human brain. At the same time, Artificial Intelligence is utilized to better understand and serve the human brain, and ultimately improve people’s lives. This session will give an overview of activities at the forefront of the work being done in applying brain inspired technologies in industry and will also outline how these advancements are being applied to better understand the human brain.

Chair: Amir Konigsberg, Co-founder and Board Director of Twiggle Inc, Israel

14:00 Yossi Matias, Vice President, Engineering at Google; Managing Director of Google's R&D Center, Israel

14:20 ATTENTION: FROM COGNITIVE NEUROSCIENCE TO COMPUTER VISION
Nilli Lavie,
Professor of Psychology and Brain Sciences and Director of the Attention and Cognitive Control laboratory at the University College London Institute of Cognitive Neuroscience, UK

14:40 FROM NEURAL NETWORKS TO DEEP LEARNING
Gal Chechik,
Director of AI at NVIDIA, Associate Professor at the Gonda Brain Research Institute, Bar Ilan University, Israel

15:00 OPENING THE BLACK-BOX OF DEEP NEURAL NETWORKS: THE INFORMATION BOTTLENECK THEORY OF DEEP LEARNING
Naftali Tishby,
Professor, Computer Science, The Hebrew University; Member of the Edmond and Lilly Safra Center for Brain Sciences (ELSC), Hebrew University, Israel

15:20 Q&A

Chair: Dana Gefen Doron, Brain Rehab specialist at Tel Hashomer Hospital, Israel

Ido Strauss, Director, Neuromodulation Unit, Department of Neurosurgery, Tel Aviv Sourasky Medical Center, Israel

REAL WORLD CHALLENGES TO PREDICTION OF PSYCHIATRIC DISORDERS
Avraham Reichenberg,
Professor of Preventive Medicine and Psychiatry at the Ichan School of Medicine at Mount Sinai in New York; Senior Fellow of the Seaver Center for Autism Research and Treatment, New York, USA

HOW THE STARTUP NATION MAY BECOME THE NATION THAT WILL PREVENT ALZHEIMER’S DISEASE?
Michal Beeri,
Director of the Sagol Neuroscience Research Center, Sheba Medical Center, Israel

THE OBSTACLES IN ADOPTING NEW TECHNOLOGIES IN NEURO-MEDICINE
Gili Givaty,
Deputy Director of Barzilai Medical Center, Israel

BrainMind is an ecosystem and platform for impact-oriented company creation in brain and mind science. Brain science is in the midst of a transformative step change in capacity, akin to the sequencing of the human genome in genetics or development of nuclear fission in physics. Emerging technologies with unprecedented ability to access and manipulate the brain and mind are being rapidly developed in the private sector, where public oversight is limited. As a species, we must proactively navigate this watershed era in neuroscience. The BrainMind ecosystem will catalyze impact-maximizing innovation in brain science with new forms of capital and leadership support for non-venture-backable ideas with the most potential to benefit humanity. Less than a year old, the platform has attracted Stanford, MIT, and Oxford and a growing list of academic collaborators. BrainMind’s leaders Michael McCullough, Ed Boyden, Laura Roberts, and Reid Hoffman have leveraged the private sector to draw together top philanthropists/foundations (>$100BN in capital), and the world’s top investors and entrepreneurs in this ecosystem to support these pivotal ideas from the lab to society.

Michael McCullough, Entrepreneur In Residence at Greylock Partners, Founder & President of BrainMind & QuestBridge, & Asst Professor of Emergency Medicine at UCSF, USA

Rafi Gidron, IBT Founder and Chairman, Israel